Although accumulating evidence shows that SIRT7 expression is increased in many subtypes of cancers, and SIRT7 ablation suppresses tumor growth64, many studies have also shown that SIRT7 loss promotes malignant progression through metastasis42,50, resistance to chemotherapy16,65, and tumor survival under energy stress16,17. This evidence concerns the gene SIRT7 and cancer.